Acute myeloid leukaemia (in remission) Recruiting Phase 2 Trials for Azacitidine (DB00928)

Also known as: Acute Myeloid Leukemia in Remission / Acute myeloid leukemia (in remission) / Acute myeloblastic leukemia, in remission / Acute myeloid leukaemia in remission

IndicationStatusPhase
DBCOND0006975 (Acute myeloid leukaemia (in remission))Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04062266Azacitidine and Venetoclax in Treating Patients With High Risk Acute Myeloid Leukemia in RemissionTreatment